Cormorant Asset Management’s Acadia Pharmaceuticals ACAD Stock Holding History

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-50,000	Closed	-$1.13M	–	65
2014 Q2	$1.13M	Sell	50,000 -250,000	-83%	-$5.65M	0.3%	50
2014 Q1	$7.3M	Sell	300,000 -500,000	-63%	-$12.2M	1.68%	26
2013 Q4	$20M	Buy	+800,000	New	+$20M	5.8%	7